Reducing Blood Culture and Antibiotic Usage in Neonates: Using Quality Improvement Science to Guide Implementation of a Neonatal Early-Onset Sepsis Calculator
- PMID: 35901468
- DOI: 10.1097/ANC.0000000000000932
Reducing Blood Culture and Antibiotic Usage in Neonates: Using Quality Improvement Science to Guide Implementation of a Neonatal Early-Onset Sepsis Calculator
Abstract
Background: A maternal diagnosis of chorioamnionitis, based on maternal peripartum fever of 100.4°F alone, is commonly used as an indication for blood work and antibiotic treatment in newborns. New strategies such as the Kaiser Permanente early-onset sepsis (EOS) calculator have proven effective in identifying high-risk newborns and reducing unnecessary antibiotic administration.
Purpose: Retrospective data from October 2017 to September 2018 from 297 well-appearing newborns ≥35 weeks' gestational age (GA) with maternal chorioamnionitis showed that 93.6% had blood work and 90.2% were treated with antibiotics. This was despite no culture-positive cases of sepsis. Our aim was to reduce by 50% blood work evaluation and antibiotic treatment within a 6-month period.
Methods: Using plan-do-study-act (PDSA) cycles, we adopted the Kaiser Permanente EOS calculator. We collected longitudinal data to track the outcomes after its implementation.
Results: In 423 newborns with maternal chorioamnionitis triaged with the EOS calculator from October 2018 to July 2020, the rates of blood culture and antibiotic treatment decreased from 93.6% to 26.7% and 90.2% to 12.3% (P < .0001). In the larger population of 6426 newborns ≥35 weeks' GA, the rate of blood culture and antibiotic treatment decreased from 12.8% to 5.8% and 9.9% to 2.5% (P < .0001).
Implications for practice: The EOS calculator substantially and safely decreases blood work and antibiotic administration in asymptomatic newborns with maternal chorioamnionitis.
Implications for research: Our findings provide further evidence for the effectiveness and safety of the EOS calculator.Video abstract available athttps://journals.lww.com/advancesinneonatalcare/Pages/videogallery.aspx.
Copyright © 2021 by The National Association of Neonatal Nurses.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Implementation of the Neonatal Sepsis Calculator in Early-Onset Sepsis and Maternal Chorioamnionitis.Adv Neonatal Care. 2020 Feb;20(1):25-32. doi: 10.1097/ANC.0000000000000668. Adv Neonatal Care. 2020. PMID: 31569094
-
Potential benefit from the implementation of the Kaiser Permanente neonatal early-onset sepsis calculator on clinical management of neonates with presumed sepsis.Eur J Pediatr. 2022 Mar;181(3):1001-1008. doi: 10.1007/s00431-021-04282-x. Epub 2021 Oct 18. Eur J Pediatr. 2022. PMID: 34664107
-
Reducing antibiotic use in asymptomatic term infants exposed to maternal chorioamnionitis: Predictive role of sepsis risk calculator.J Paediatr Child Health. 2022 Nov;58(11):1958-1963. doi: 10.1111/jpc.16128. Epub 2022 Jul 23. J Paediatr Child Health. 2022. PMID: 35869737
-
Neonatal Sepsis: A Review of Pathophysiology and Current Management Strategies.Adv Neonatal Care. 2021 Feb 1;21(1):49-60. doi: 10.1097/ANC.0000000000000769. Adv Neonatal Care. 2021. PMID: 32956076 Review.
-
Sepsis calculator for neonatal early onset sepsis - a systematic review and meta-analysis.J Matern Fetal Neonatal Med. 2021 Jun;34(11):1832-1840. doi: 10.1080/14767058.2019.1649650. Epub 2019 Aug 11. J Matern Fetal Neonatal Med. 2021. PMID: 31352846
Cited by
-
Disease burden comparison and associated risk factors of early- and late-onset neonatal sepsis in China and the USA, 1990-2019.Glob Health Action. 2024 Dec 31;17(1):2396734. doi: 10.1080/16549716.2024.2396734. Epub 2024 Sep 4. Glob Health Action. 2024. PMID: 39229931 Free PMC article.
-
Improving the Treatment of Neonatal Sepsis in Resource-Limited Settings: Gaps and Recommendations.Res Rep Trop Med. 2023 Dec 14;14:121-134. doi: 10.2147/RRTM.S410785. eCollection 2023. Res Rep Trop Med. 2023. PMID: 38116466 Free PMC article. Review.
-
Early initiation of antibiotic therapy and short-term outcomes in preterm infants: a single-centre retrospective cohort analysis.Arch Dis Child Fetal Neonatal Ed. 2023 Nov;108(6):623-630. doi: 10.1136/archdischild-2022-325113. Epub 2023 May 3. Arch Dis Child Fetal Neonatal Ed. 2023. PMID: 37137680 Free PMC article.
References
-
- Puopolo KM, Benitz WE, Zaoutis TE, Committee on Infectious Diseases. Management of neonates born at ≥35 0/7 weeks' gestation with suspected or proven early-onset bacterial sepsis. Pediatrics. 2018;142(6):e20182894.
-
- Prevention of Group B streptococcal early-onset disease in newborns: ACOG Committee Opinion Summary, Number 782. Obstet Gynecol. 2019;134(1):206–210.
-
- Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease. MMWR Recomm Rep. 2010;59(RR-10):1–32.
-
- Mukhopadhyay S, Eichenwald EC, Puopolo KM. Neonatal early-onset sepsis evaluations among well-appearing infants: projected impact of changes in CDC GBS guidelines. J Perinatol. 2013;33(3):198–205.
-
- Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser MJ. Infant antibiotic exposures and early-life body mass. Int J Obes (Lond). 2013;37(1):16–23.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical